Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

Miguel Cuevas, Alejandra de-la-Torre, Andrea Córdoba

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.

Translated title of the contribution Despigmentación bilateral del iris e hipotonía ocular como manifestaciones en fase terminal de la enfermedad de Vogt-Koyanagi-Harada no tratada.
Original languageEnglish (US)
Article numberPMID: 28548582
Pages (from-to)1-6
Number of pages6
JournalOcular Immunology and Inflammation
Early online dateMar 26 2017
DOIs
StatePublished - May 26 2017

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Ophthalmology

Concepts

  • Concept
  • Iris atrophy
  • Iris depigmentations
  • VKH; Vogt–Koyanagi–Harada disease
  • ocular hypotony
  • panuveitis

Fingerprint

Dive into the research topics of 'Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.'. Together they form a unique fingerprint.

Cite this